Published in Proc Natl Acad Sci U S A on April 25, 2011
Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol (2014) 2.82
The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol (2011) 2.29
Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio (2013) 2.17
Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science (2014) 1.92
Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science (2014) 1.90
Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol (2015) 1.76
Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med (2015) 1.74
Induction and function of type I and III interferon in response to viral infection. Curr Opin Virol (2011) 1.61
Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection. PLoS Pathog (2014) 1.59
Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections. PLoS Pathog (2016) 1.51
MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science (2016) 1.49
Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog (2012) 1.48
IFN-λs. Curr Opin Immunol (2011) 1.48
Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology (2014) 1.46
IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nat Immunol (2017) 1.45
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J (2013) 1.40
Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep (2012) 1.37
The regulation of inflammation by interferons and their STATs. JAKSTAT (2013) 1.35
IFN-λ4: the paradoxical new member of the interferon lambda family. J Interferon Cytokine Res (2014) 1.32
Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol (2015) 1.22
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond. Immunity (2015) 1.16
Guarding the frontiers: the biology of type III interferons. Nat Immunol (2015) 1.12
Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science (2014) 1.12
Rotavirus immune responses and correlates of protection. Curr Opin Virol (2012) 1.11
Active suppression of intestinal CD4(+)TCRαβ(+) T-lymphocyte maturation during the postnatal period. Nat Commun (2015) 1.09
A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS One (2011) 1.07
Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04
Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections. PLoS Pathog (2015) 1.01
The battle between rotavirus and its host for control of the interferon signaling pathway. PLoS Pathog (2013) 1.00
Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proc Natl Acad Sci U S A (2012) 0.99
Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes. Mol Cancer Res (2014) 0.99
Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS One (2012) 0.98
Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection. PLoS One (2013) 0.95
Neonatal immune adaptation of the gut and its role during infections. Clin Dev Immunol (2013) 0.95
Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle. J Virol (2012) 0.94
Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells. PLoS One (2012) 0.93
Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol (2014) 0.93
Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. PLoS Biol (2014) 0.93
Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain. J Virol (2013) 0.91
Long-distance interferon signaling within the brain blocks virus spread. J Virol (2014) 0.90
Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans. PLoS Pathog (2015) 0.89
The role of type I interferons in intestinal infection, homeostasis, and inflammation. Immunol Rev (2014) 0.89
The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol (2014) 0.88
Nlrp6 regulates intestinal antiviral innate immunity. Science (2015) 0.88
Viral interactions with the host and microbiota in the intestine. Curr Opin Immunol (2012) 0.87
IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment. EMBO Mol Med (2016) 0.87
STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity. Mol Cell Biol (2014) 0.86
Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells. Genes Immun (2015) 0.86
Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells. PLoS One (2013) 0.85
The influence of commensal bacteria on infection with enteric viruses. Nat Rev Microbiol (2016) 0.84
The unique regulation and functions of type III interferons in antiviral immunity. Curr Opin Virol (2015) 0.83
Post-transcriptional regulation of interferons and their signaling pathways. J Interferon Cytokine Res (2014) 0.82
Impact and regulation of lambda interferon response in human metapneumovirus infection. J Virol (2014) 0.82
Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses. Ann Allergy Asthma Immunol (2013) 0.82
Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance. Nat Commun (2015) 0.81
Dietary Lactobacillus rhamnosus GG Supplementation Improves the Mucosal Barrier Function in the Intestine of Weaned Piglets Challenged by Porcine Rotavirus. PLoS One (2016) 0.81
Generation of mouse small intestinal epithelial cell lines that allow the analysis of specific innate immune functions. PLoS One (2013) 0.80
Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways. Gut (2014) 0.80
Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms. PLoS Pathog (2015) 0.80
Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons. Mol Cell Biol (2015) 0.80
Type I interferon response is delayed in human astrovirus infections. PLoS One (2015) 0.79
Antiviral activity of lambda interferon in chickens. J Virol (2013) 0.79
Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence. J Interferon Cytokine Res (2015) 0.79
Telomerase Activity is Downregulated Early During Human Brain Development. Genes (Basel) (2016) 0.79
Dietary Leucine Supplementation Improves the Mucin Production in the Jejunal Mucosa of the Weaned Pigs Challenged by Porcine Rotavirus. PLoS One (2015) 0.78
Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus. PLoS Pathog (2015) 0.78
Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of IFN-lambda against norovirus and reovirus. J Virol (2017) 0.78
Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res (2016) 0.78
Innate Immunity and Immune Evasion by Enterovirus 71. Viruses (2015) 0.77
IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection. J Immunol (2014) 0.77
Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2. J Virol (2013) 0.77
Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System. PLoS Pathog (2015) 0.77
Organotypic models of type III interferon-mediated protection from Zika virus infections at the maternal-fetal interface. Proc Natl Acad Sci U S A (2017) 0.76
Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8]. J Virol (2015) 0.76
Interferon lambda 4 expression is suppressed by the host during viral infection. J Exp Med (2016) 0.76
Identification of Toll-like receptor 9 as parapoxvirus ovis-sensing receptor in plasmacytoid dendritic cells. PLoS One (2014) 0.76
Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes. Drug Des Devel Ther (2016) 0.76
OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production. Sci Rep (2016) 0.76
Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut. Front Immunol (2017) 0.76
A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc Natl Acad Sci U S A (2017) 0.75
Contribution of Type III Interferons to Antiviral Immunity; Location, Location, Location. J Biol Chem (2017) 0.75
Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology. Front Immunol (2017) 0.75
Oral administration of Lactococcus lactis subsp. lactis JCM5805 enhances lung immune response resulting in protection from murine parainfluenza virus infection. PLoS One (2015) 0.75
IFN-λ: A New Inducer of Local Immunity against Cancer and Infections. Front Immunol (2016) 0.75
IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research. Gastroenterol Res Pract (2015) 0.75
Early type I Interferon response induces upregulation of human β-defensin 1 during acute HIV-1 infection. PLoS One (2017) 0.75
Mumps Virus Induces Protein-Kinase-R-Dependent Stress Granules, Partly Suppressing Type III Interferon Production. PLoS One (2016) 0.75
STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α. Sci Rep (2016) 0.75
Interferon Lambda: Modulating Immunity in Infectious Diseases. Front Immunol (2017) 0.75
Identification, Characterization, and Developmental Expression Pattern of Type III Interferon Receptor Gene in the Chinese Goose. Biomed Res Int (2015) 0.75
Tollip SNP rs5743899 modulates human airway epithelial responses to rhinovirus infection. Clin Exp Allergy (2016) 0.75
Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections. Front Immunol (2017) 0.75
Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset. Front Endocrinol (Lausanne) (2017) 0.75
Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression. Front Immunol (2017) 0.75
The innate immune receptor MDA5 limits rotavirus infection but promotes cell death and pancreatic inflammation. EMBO J (2017) 0.75
Cell Polarization and Epigenetic Status Shape the Heterogeneous Response to Type III Interferons in Intestinal Epithelial Cells. Front Immunol (2017) 0.75
Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract. Front Immunol (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol (2002) 11.87
IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol (2002) 11.22
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol (2008) 8.85
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med (2005) 6.59
STAT1-dependent innate immunity to a Norwalk-like virus. Science (2003) 6.35
Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol (1979) 4.86
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog (2008) 4.70
Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol (2005) 3.89
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol (2008) 3.75
Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med (2006) 3.12
IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J Immunol (2004) 2.60
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem (2004) 2.55
Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem (2007) 2.40
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol (2006) 2.38
Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res (2006) 2.34
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses. Virology (1985) 2.26
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity (2005) 2.16
The host type I interferon response to viral and bacterial infections. Cell Res (2005) 2.12
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol (2005) 2.05
The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol (2007) 1.93
CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J Immunol (2006) 1.92
A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J Virol (1988) 1.90
Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem (2009) 1.73
Immunity to homologous rotavirus infection in adult mice. Trends Microbiol (2000) 1.62
A recombinant human interferon-alpha B/D hybrid with a broad host-range. J Gen Virol (1987) 1.42
Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol (2003) 1.31
Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice. J Interferon Cytokine Res (1999) 1.20
The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res (2003) 1.19
Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol (2010) 1.18
Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice. J Virol (2004) 0.88
IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog (2008) 4.70
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol (2008) 3.75
The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol (2005) 3.65
Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med (2006) 3.12
miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host Microbe (2010) 2.65
Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem (2004) 2.55
Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog (2008) 2.38
Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A (2007) 2.33
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol (2005) 2.26
Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity (2012) 2.23
Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics (2010) 2.08
IFNs and STATs in innate immunity to microorganisms. J Clin Invest (2002) 2.04
Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A (2006) 2.02
Interferon-induced Mx proteins in antiviral host defense. Biochimie (2007) 2.00
The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol (2007) 1.93
Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol (2010) 1.92
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Protective role of beta interferon in host defense against influenza A virus. J Virol (2006) 1.80
Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models. J Virol (2010) 1.72
Characterization of the murine alpha interferon gene family. J Virol (2004) 1.72
Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol (2009) 1.69
High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One (2010) 1.68
Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc Natl Acad Sci U S A (2005) 1.61
The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol (2004) 1.58
Broad tissue and cell tropism of avian bornavirus in parrots with proventricular dilatation disease. J Virol (2009) 1.57
Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility. PLoS Pathog (2012) 1.48
The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol (2007) 1.47
Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J Virol (2002) 1.41
Selective virus resistance conferred by expression of Borna disease virus nucleocapsid components. J Virol (2003) 1.40
Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflamm Bowel Dis (2014) 1.38
Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol (2007) 1.38
The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J Immunol (2007) 1.33
Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol (2009) 1.32
Transcription factor redundancy ensures induction of the antiviral state. J Biol Chem (2010) 1.32
Potentiation of epithelial innate host responses by intercellular communication. PLoS Pathog (2010) 1.31
Type I interferon response in the central nervous system. Biochimie (2007) 1.29
Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein. J Virol (2003) 1.27
Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J Gen Virol (2006) 1.27
Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway. Eur J Immunol (2007) 1.24
Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol (2009) 1.22
Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol (2010) 1.18
Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J Virol (2009) 1.18
Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J Virol (2002) 1.16
Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J Gen Virol (2009) 1.16
Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog (2013) 1.15
The leader protein of cardioviruses inhibits stress granule assembly. J Virol (2011) 1.14
Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response. J Virol (2010) 1.13
Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. J Biol Chem (2003) 1.12
Developmental switch of intestinal antimicrobial peptide expression. J Exp Med (2008) 1.11
Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci (2007) 1.11
Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus. J Gen Virol (2012) 1.10
Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence. Cell Microbiol (2007) 1.09
High-avidity human serum antibodies recognizing linear epitopes of Borna disease virus proteins. Biol Psychiatry (2002) 1.08
Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe (2012) 1.06
Rat model of borna disease virus transmission: epidemiological implications. J Virol (2003) 1.06
The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J Virol (2013) 1.06
Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle (2007) 1.05
Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL. J Immunol (2009) 1.05
Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol (2009) 1.04
Random mutagenesis defines a domain of Theiler's virus leader protein that is essential for antagonism of nucleocytoplasmic trafficking and cytokine gene expression. J Virol (2009) 1.03
IFN-beta increases listeriolysin O-induced membrane permeabilization and death of macrophages. J Immunol (2008) 1.02
Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L. PLoS Pathog (2013) 1.02
The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein. J Gen Virol (2004) 1.00
Cytoplasmic Listeria monocytogenes stimulates IFN-beta synthesis without requiring the adapter protein MAVS. FEBS Lett (2006) 1.00
Synthesis of IFN-beta by virus-infected chicken embryo cells demonstrated with specific antisera and a new bioassay. J Interferon Cytokine Res (2004) 1.00
Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling. J Immunol (2011) 0.99
MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury. EMBO Mol Med (2012) 0.99
Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS One (2012) 0.98
Avian bornaviruses are widely distributed in canary birds (Serinus canaria f. domestica). Vet Microbiol (2013) 0.98
IL-18 stimulates the proliferation and IFN-gamma release of CD4+ T cells in the chicken: conservation of a Th1-like system in a nonmammalian species. J Immunol (2003) 0.97
Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol (2012) 0.97
Nyamiviridae: proposal for a new family in the order Mononegavirales. Arch Virol (2013) 0.96
Interferon-λ in the context of viral infections: production, response and therapeutic implications. J Innate Immun (2014) 0.96
CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage. J Virol (2005) 0.94
O-antigen delays lipopolysaccharide recognition and impairs antibacterial host defense in murine intestinal epithelial cells. PLoS Pathog (2009) 0.93
Protein X of Borna disease virus inhibits apoptosis and promotes viral persistence in the central nervous systems of newborn-infected rats. J Virol (2009) 0.93
Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo. J Virol (2011) 0.93
Establishment of intestinal homeostasis during the neonatal period. Cell Mol Life Sci (2011) 0.92
N-glycosylation of murine IFN-beta in a putative receptor-binding region. J Interferon Cytokine Res (2006) 0.92
Overlap of interaction domains indicates a central role of the P protein in assembly and regulation of the Borna disease virus polymerase complex. J Biol Chem (2004) 0.92
Polymerase read-through at the first transcription termination site contributes to regulation of borna disease virus gene expression. J Virol (2008) 0.92
Visualizing viral dissemination in the mouse nervous system, using a green fluorescent protein-expressing Borna disease virus vector. J Virol (2010) 0.92
What have we learned from the IL28 receptor knockout mouse? J Interferon Cytokine Res (2010) 0.91
Serological evidence for Borna disease virus infection in humans, wild rodents and other vertebrates in Finland. J Clin Virol (2006) 0.91
A Borna disease virus vector for expression of foreign genes in neurons of rodents. J Virol (2007) 0.91
Acetylation of H3 K56 is required for RNA polymerase II transcript elongation through heterochromatin in yeast. Mol Cell Biol (2010) 0.91